Technical Articles

KRAS G12V & CRBN Binding Kit (GTP load)

Precision treatment strategy for pancreatic cancer with KRAS G12V mutation and HLA-A*11:01 positivity

2026-03-03

Pancreatic cancer, due to its hidden anatomical location, atypical early symptoms, rapid progression, and limited treatment options, has long ranked among the top in malignancy mortality rates, earning it the title "king of cancers."

View details

Cancer
KRAS G12V & CRBN Binding Kit (GTP load)
Pancreatic cancer
Malignant tumor

Total 1

Go to